Global markets rebounded last week as fears a global trade war would erupt in the first days of Trump’s presidency were assuaged after the President avoided placing immediate import levies on goods from Mexico, Canada and China. Threats resurfaced, however, after Trump ordered punitive trade sanctions on Colombia Sunday for rejecting US deportation flights over human rights issues.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected
January 30, 2025